Valuation Sigyn Therapeutics, Inc.

Stocks

Market Closed - OTC Markets 14:29:43 2026-05-27 EDT			5-day change	1st Jan Change
0.0316 ^USD	-18.97%		-9.71%	-98.15%

05-07	Oragenics signs letter of intent to license Cardiodialysis(TM) technology from Sigyn Therapeutics to target TBI-induced systemic inflammation	RE
05-07	Oragenics Signs Letter of Intent to License CardioDialysis? Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024
Market Cap ¹	43.76	18.65	6.34	6.077	5.057
Change	-	-57.38%	-66%	-4.15%	-16.78%
Enterprise Value (EV)	44.19	19.24	8.209	8.543	7.237
Change	-	-56.46%	-57.33%	4.06%	-15.29%
P/E	-7.47x	-6.06x	-2.13x	-1.25x	-1.25x
PBR	454x	-70.5x	-3.42x	-1.79x	-1.13x
PEG	-	0.1x	0.69x	-0.1x	0x
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-6.854	-3.302	-3.2	-3.77	-2.51
Distribution rate	-	-	-	-	-
Net sales	-	-	-	-	-
EBITDA	-0.9051	-2.525	-2.137	-2.446	-2.514
EBIT ¹	-0.9164	-2.544	-2.147	-2.455	-2.519
Net income ¹	-1.26	-3.005	-2.93	-4.146	-3.34
Net Debt	0.4343	0.593	1.869	2.466	2.18
Reference price ²	51.2000	20.0000	6.8000	4.7300	3.1500
Nbr of stocks (in thousands)	855	932	932	1,285	1,605
Announcement Date	4/6/21	3/21/22	3/31/23	2/20/24	4/15/25

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SIGYN THERAPEUTICS, INC.	-	-	-	-	160K
ABBOTT LABORATORIES	30.95x	4.09x	15.82x	2.45%	181B
MEDTRONIC PLC	20.26x	3.52x	12.59x	2.99%	116B
STRYKER CORPORATION	22.98x	4.5x	15.69x	1.22%	113B
ESSILORLUXOTTICA	27.35x	2.68x	10.75x	2.64%	79.83B
CENCORA, INC.	18.7x	0.22x	13.49x	0.7%	65.06B
HOYA CORPORATION	31.17x	7.75x	19.98x	1.28%	54.35B
BECTON, DICKINSON AND COMPANY	36.95x	3.53x	12.1x	2.05%	52.23B
IDEXX LABORATORIES, INC.	37.95x	9.42x	26.36x	-.--%	44.15B
DEXCOM, INC.	34.57x	6.06x	19.03x	-.--%	32.47B
Average	28.99x	4.64x	16.20x	1.48%	73.86B
Weighted average by Cap.	27.60x	4.20x	15.35x	1.84%